[1]
H. Meriyani, D. A. Sanjaya, R. A. Juanita, N. B. Siada, and N. Chusna, “Eribulin Effectiveness and Safety in Metastatic Triple-Negative Breast Cancer: A Narrative Review”,
Borneo J Pharm
, vol. 8, no. 1, pp. 33–48, Feb. 2025.